Journals / Türk Oftalmoloji Dergisi / 2011 / Cilt: 41 - Sayı: 3

Non-recurrence Complıcatıons of Pterygıum Surgery

Pterjiyum Cerrahisinin Nüks Dışı Komplikasyonları

Pages
151–155
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Perioperative antimitotic agent use should be saved for selected cases, excessive cauterisation and wide surgical dissections that might trigger cicatrisation must be avoided. (Turk J Ophthalmol 2011; 41: 151-5)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To draw attention to non-recurrence complications of pterygium surgery by reporting the cases of patients who were referred to our clinic.
📊
Key Findings & Data:Material and Method: The data of 20 eyes of 18 patients were evaluated retrospectively.
💡
Conclusion & Impact:Perioperative antimitotic agent use should be saved for selected cases, excessive cauterisation and wide surgical dissections that might trigger cicatrisation must be avoided. (Turk J Ophthalmol 2011; 41: 151-5)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To draw attention to non-recurrence complications of pterygium surgery by reporting the cases of patients who were referred to our clinic. Material and Method: The data of 20 eyes of 18 patients were evaluated retrospectively. Age, gender, accompanying diseases, best corrected visual acuities at the time of referral and at last visit, and data related to primary surgery were assessed. The treatment modalities we used were noted. Results: The mean age of the patients was 51.62±9.86 (range: 37-67) years. All cases had been operated for primary pterygium. Bare sclera technique had been used in 9 eyes and intraoperative mitomycin C (MMC) had been applied in 9 eyes. Complications related to poor suturing technique were observed in 5 eyes and to excessive cauterisation - in 3 eyes. The detected complications were pyogenic granuloma, inclusion cyst, dellen, scleromalacia, limbal insufficiency, and globe perforation. Medical therapy was sufficient in 6 cases, whereas the remaining 14 eyes had to undergo surgical treatment. Discussion: Pterygium surgery should not be underestimated. Maximum attention must be paid in every step of the surgery and complications that might develop related to adjuvant agents should not be neglected. Perioperative antimitotic agent use should be saved for selected cases, excessive cauterisation and wide surgical dissections that might trigger cicatrisation must be avoided. (Turk J Ophthalmol 2011; 41: 151-5)

Özet

Amaç: Kliniğimize yönlendirilmiş olguları sunarak pterjiyumun nüks dışı komplikasyonlarına dikkat çekmek. Gereç ve Yöntem: Kliniğimize yönlendirilen 18 hastanın 20 gözüne ait veriler retrospektif olarak değerlendirildi. Olguların yaş, cinsiyet, eşlik eden hastalıkları, başvuru anındaki ve sonuç en iyi düzeltilmiş görme keskinlikleri, primer cerrahiye ait bilgileri de¤erlendirildi. Uyguladığmız tedavi yöntemleri not edildi. Sonuçlar: Olgunun yaş ortalaması 51,62±9,86 (37 ve 67 arasında) idi. Olguların tamamı primer pterjiyum nedeniyle opere edilmişltir. Dokuz gözde çıplak sklera tekniği, 9 gözde intraoperatif Mitomisin C (MMC) uygulanmıştır›. Befl gözde kötü yara dudağı sütürasyonu, 3 gözde ise aşırı koter kullanımına bağlı komplikasyon geliştiği izlendi. Saptanan komplikasyonlar pyojenik granülom, inklüzyon kisti, Dellen, skleromalazi, limbal yetmezlik ve perforan yaralanma idi. Altı gözde tıbbi tedavi yeterli olurken, geri kalan 14 göze cerrahi tedavi uygulandı. Tartışma: Pterjiyum cerrahisi hafife alınmamalıdır. Cerrahinin her aşamasınnda azami dikkat gösterilmeli ve adjuvan ajanlara bağlğ gelişebilecek komplikasyonlar unutulmamalıdır. Peroperatuar antimitotik ajan kullanımı seçilmiş vakalara saklanmalı, aşırı koterizasyon ve skatrizasyonu tetikleyecek genifl cerrahi diseksiyonlardan kaçınılmalıdır. (Turk J Ophthalmol 2011; 41: 151-5)

🔖

Cite This Article

YAĞCI, A., EĞRİLMEZ, S., ONAY, M. P. (2022). Non-recurrence Complıcatıons of Pterygıum Surgery. Türk Oftalmoloji Dergisi, Cilt: 41 - Sayı: 3, 151–155. https://ajindex.com/articles/638379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;45:145-80.
  2. Fernandes M, Sangwan VS, Bansal AK, et al. Outcome of pterygium surgery: analysis over 14 years. Eye (Lond). 2005;19:1182-90.
  3. Torun AB, Y›lmaz T, Ülkü G, Arslanhan O. Primer pterjiyum eksizyonundan sonra topikal siklosporin A tedavisinin etkinli¤i. Turk J Ophthalmol. 2010;40:71-5.
  4. Alpay A, U¤urbafl SH, Erdo¤an B. Comparing techniques for pterygium surgery. Clin Ophthalmol. 2009;3:69-74.
  5. Koç F, Demirbay P, Teke MY, et al. Primer ve rekürren pterjiyumda konjonktival otogreftleme. Turk J Ophthalmol. 2002;32:583-8.
  6. Jain V, Shome D, Natarajan S, Narverkar R. Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft. Cornea. 2008;27:720-1.
  7. Karalezli A, Kucukerdonmez C, Borazan M, Akova YA. Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit. 2010;29:88-90.
  8. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647-54.
  9. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol. 1980;64:496-505.
  10. Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO. Intraoperative Mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology. 1998;105:901-4.
  11. Cheng HC, Tseng SH, Kao PL, Chen FK. Low-dose intraoperative Mitomycin C as chemoadjuvant for pterygium surgery. Cornea. 2001;20:24-9.
  12. Altiparmak UE, Kat›rc›o¤lu YA, Ya¤c› R, Yaln›z Z, Duman S. Mitomycin C and conjunctival autograft for recurrent pterygium. Int Ophthalmol. 2007;27:339-43.